tradingkey.logo
tradingkey.logo
Search

Quantum BioPharma Ltd

QNTM
Add to Watchlist
2.890USD
+0.050+1.76%
Close 07-31 16:00ETQuotes delayed by 15 min
11.24MMarket Cap
LossP/E TTM

QNTM Financials

See Quantum BioPharma Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Quantum BioPharma Ltd Earnings Date

Latest Release
May 6, 2026
EPS / Forecast
-3.02/-0.07
Revenue / Forecast
--/1.87M
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-7.97
36.23%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
12.84%-3.02
67.00%-0.79
68.01%-1.40
41.42%-3.06
-1.09%-3.47
-9.56%-2.39
-133.21%-4.37
42.52%-5.23
79.36%-3.43
79.08%-2.18
---1.88
---9.10
---16.61
---10.44
---29.18
----
----
----
----
----
Net Profit
-58.11%-13.56M
36.20%-3.03M
-32.47%-5.32M
-176.01%-9.25M
-310.09%-8.58M
-258.50%-4.74M
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
78.48%-1.32M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
3.14%-6.15M
-23.10%-7.13M
66.50%-4.42M
40.59%-5.91M
-30.43%-6.35M
57.21%-5.79M
-193.99%-13.21M
Debt to assets ratio
-32.28%5.83%
248.86%16.81%
821.55%18.07%
261.12%14.81%
113.03%8.61%
148.25%4.82%
2.34%1.96%
110.18%4.10%
155.41%4.04%
44.37%1.94%
--1.92%
--1.95%
--1.58%
--1.34%
--1.28%
----
----
----
----
----
Operating profit
12.69%-2.97M
61.97%-2.37M
-11.89%-4.68M
-40.41%-4.85M
-50.50%-3.40M
-298.82%-6.24M
-26.24%-4.18M
30.76%-3.46M
75.90%-2.26M
76.50%-1.56M
54.35%-3.31M
36.54%-4.99M
-65.76%-9.36M
-8.84%-6.66M
-41.33%-7.25M
38.01%-7.87M
42.37%-5.65M
4.21%-6.12M
58.69%-5.13M
-162.77%-12.69M
Net Profit
-58.11%-13.56M
36.20%-3.03M
-32.47%-5.32M
-176.01%-9.25M
-310.09%-8.58M
-258.50%-4.74M
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
78.48%-1.32M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
3.14%-6.15M
-23.10%-7.13M
66.50%-4.42M
40.59%-5.91M
-30.43%-6.35M
57.21%-5.79M
-193.99%-13.21M
Current assets
4.40%10.37M
-46.25%6.48M
-32.51%9.34M
3.21%10.34M
8.06%9.93M
8.73%12.05M
49.72%13.84M
10.05%10.02M
-14.36%9.19M
-37.90%11.09M
-63.25%9.25M
-73.22%9.11M
-72.92%10.73M
-61.14%17.85M
-49.56%25.16M
-37.14%34.01M
-34.85%39.63M
70.97%45.93M
87.23%49.87M
150.16%54.10M
Total current liabilities
58.02%16.35M
-9.29%6.06M
80.56%6.65M
162.64%13.25M
163.62%10.34M
46.29%6.68M
-12.25%3.68M
-13.75%5.04M
-54.37%3.92M
-41.69%4.57M
-43.16%4.20M
-31.52%5.85M
-2.91%8.60M
-10.01%7.83M
-12.84%7.38M
-14.69%8.54M
12.57%8.86M
55.95%8.70M
-16.63%8.47M
123.67%10.01M
Total assets
0.35%14.93M
-34.80%11.16M
-25.61%14.15M
0.33%15.30M
-3.66%14.87M
-2.03%17.12M
0.45%19.03M
-28.78%15.25M
-47.63%15.44M
-54.51%17.47M
-56.54%18.94M
-58.16%21.41M
-47.08%29.48M
-38.99%38.41M
-36.53%43.58M
-25.13%51.17M
-27.12%55.71M
50.03%62.96M
62.74%68.67M
78.34%68.35M
Total liabilities
58.02%16.35M
-9.29%6.06M
80.56%6.65M
162.64%13.25M
163.62%10.34M
46.29%6.68M
-12.25%3.68M
-13.89%5.04M
-54.50%3.92M
-41.98%4.57M
-43.61%4.20M
-31.80%5.86M
-3.64%8.62M
-10.91%7.87M
-12.67%7.44M
-14.73%8.59M
12.73%8.95M
56.08%8.83M
-16.82%8.52M
120.53%10.07M
Total equity
-131.35%-1.42M
-51.13%5.10M
-51.08%7.51M
-79.94%2.05M
-60.67%4.53M
-19.13%10.44M
4.06%15.35M
-34.39%10.20M
-44.79%11.51M
-57.73%12.91M
-59.20%14.75M
-63.48%15.55M
-55.40%20.86M
-43.58%30.54M
-39.91%36.14M
-26.93%42.58M
-31.74%46.76M
49.09%54.13M
88.23%60.15M
72.63%58.28M
Net operating income
60.84%-1.67M
63.43%-305.60K
50.26%-1.72M
-221.38%-1.95M
-115.91%-4.26M
1.87%-835.76K
-102.08%-3.46M
82.72%-606.48K
58.49%-1.97M
86.54%-851.65K
77.21%-1.71M
62.66%-3.51M
6.66%-4.75M
-54.64%-6.33M
-63.85%-7.52M
-42.74%-9.40M
7.13%-5.09M
18.62%-4.09M
10.59%-4.59M
-76.87%-6.58M
Net investment
-114.28%-2.89M
-71.81%350.65K
111.79%408.42K
-284.41%-1.36M
-5998.50%-1.35M
--1.24M
-1184.78%-3.46M
--738.22K
---22.14K
100.00%0.00
-178.15%-269.58K
-100.00%0.00
100.00%0.00
-27503.36%-13.12M
-113.44%-96.92K
--12.72M
78.68%-106.59K
-58.51%47.89K
587.56%721.07K
-100.00%0.00
Net financing
123.35%7.00M
-42.68%1.41M
-96.12%261.43K
-30.09%1.29M
450.97%3.13M
9885.24%2.47M
12400.66%6.74M
4378.90%1.84M
118.94%568.72K
49.10%-25.22K
78.75%-54.78K
84.34%-43.11K
-102.02%-3.00M
-283.67%-49.54K
-1582.25%-257.77K
-373.32%-275.25K
-103.88%-1.49M
-100.15%-12.91K
-100.17%-15.32K
-100.84%-58.15K

FAQs

What are the current assets of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its current assets were 6.48M, with a year-on-year change of -46.25.

What are the total assets of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its total assets of Quantum BioPharma Ltd were 11.16M, with a year-on-year change of -34.80.

What are the total liabilities of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its total liabilities of Quantum BioPharma Ltd were 6.06M, with a year-on-year change of -9.29.

What is the total equity of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its total equity of Quantum BioPharma Ltd was 5.10M, with a year-on-year change of -51.13.

What is the net operating income of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its net operating income of Quantum BioPharma Ltd was -15.30M, with a year-on-year change of 5.17.

What is the net investment of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its net investment of Quantum BioPharma Ltd was -1.95M, with a year-on-year change of -29.86.

What is the net financing of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its net financing of Quantum BioPharma Ltd was 6.10M, with a year-on-year change of -47.51.

What is the Earnings Per Share (EPS) of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -7.97, with a year-on-year change of 36.23.

What is the net income of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its net income was -26.18M, with a year-on-year change of -84.30.

What is the debt-to-asset ratio of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its debt-to-asset ratio was 16.81, with a year-on-year change of 248.86.

What is the Return on Equity (ROE) of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its Return on Equity (ROE) was -284.44, with a year-on-year change of -147.51.

What is the Return on Assets (ROA) of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its Return on Assets (ROA) was -190.64, with a year-on-year change of -121.08.

What is the operating profit of Quantum BioPharma Ltd?

According to Quantum BioPharma Ltd's FY2025 earnings report, its operating profit was -15.30M, with a year-on-year change of 5.17.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.